Juul Sandra
Department of Paediatrics, Neonatology Division, University of Washington, Seattle, Washington 98195-6320, USA.
J Matern Fetal Neonatal Med. 2012 Oct;25 Suppl 4:105-7. doi: 10.3109/14767058.2012.715025.
This review summarizes target populations of neonates for which erythropoietin (Epo) neuroprotective therapy might be of benefit, and the mechanisms by which Epo functions as a neuroprotective agent. Potential risks of Epo are reviewed. Finally, the progression of Epo neuroprotection from preclinical studies to translational studies is discussed.
本综述总结了促红细胞生成素(Epo)神经保护疗法可能有益的新生儿目标人群,以及Epo作为神经保护剂发挥作用的机制。还综述了Epo的潜在风险。最后,讨论了Epo神经保护从临床前研究到转化研究的进展。